strategies that are better able to prevent and manage chronic disease.
Various approaches and models of care for the management of chronic disease have been proposed over the past few decades. [5] [6] [7] [8] [9] [10] [11] While the literature suggests that aspects of these models may help to improve individual and systemic outcomes, 5, 7, 12, 13 the evidence of effectiveness for most of these models of care is limited. 14 These models of care have also encountered a number of criticisms, including poor ecological validity (ie limited uptake of such models because of the constraints of mainstream health systems and the inadequate preparedness of clinicians to practice within such models), wide variability (of core elements) and medicocentrism. 13, 15, 16 While a medicocentric/conventional biomedical approach may be useful for treating acute, particularly life-threatening conditions, it may not be compatible with the principles of chronic disease management. 17 According to the Pan American Health Organization, 17 the management of chronic disease should be patient-centred, proactive and prevention-focussed, as opposed to the diseasecentred, reactive and treatment-focussed conventional biomedical approach; the model of care also should be collaborative and integrated. This is a view shared by a number of authorities. 18, 19 An approach that appears to be better aligned with the principles of chronic disease management, and less medicocentric than other chronic disease models of care, is integrative healthcare.
This approach represents 'a client-centred model of care provided by a team of biomedical, allied and complementary health professionals, which work collaboratively and respectfully to deliver accessible, holistic, evidence-based, personalised, co-ordinated care that emphasises disease prevention and health, healing and wellness promotion'. 21 Unlike other models of care, interest in integrative healthcare has escalated over the past few decades.
This interest has manifested in several ways, including a global rise in the number of professional associations, clinics, journals, and Academic Chairs dedicated to IHC. This suggests that an integrative healthcare model may have some degree of ecological validity.
However, not dissimilar to chronic disease models of care, there is considerable variability in how integrative healthcare is practiced across the globe. 22, 23 While IHC appears to address several of the criticisms of existing chronic disease models of care, and there is evidence of health consumer and health provider support for adopting an IHC approach for chronic disease management, 28 there is still uncertainty regarding the effectiveness of IHC for managing complex, long-term health conditions.
While previous reviews of the effectiveness of IHC have been published, the literature searches are now more than seven years old 29 ; as such, these reviews no longer reflect the state of the art.
Furthermore, the scope of previous reviews of IHC have been limited to clinical outcomes 29 and processes of care 30 ; no known reviews have explored the impact of IHC on service-related outcomes.
A contemporary, comprehensive and systematic review of the best available evidence of the effectiveness of integrative healthcare for the management of chronic disease, which considers both patientand service-related outcomes, is therefore warranted.
| ME THODS

| Objective
This systematic review sought to find and synthesise the best available evidence of the effectiveness of integrative healthcare for the management of any chronic health condition.
| Selection criteria
The review considered all published and unpublished comparative/controlled trials investigating the effectiveness of integrative healthcare in human subjects with a chronic health condition. For the purpose of this review, integrative healthcare was defined as a healthcare service delivery model in which clinical service provision is delivered by both complementary and alternative medicine (CAM) and conventional healthcare providers (ie at least one CAM service and one conventional medicine service). The emphasis here is that IHC is a team approach, unlike integrative medicine, which is a single disciplinary approach. Thus, investigations examining integrative healthcare from the perspective of a single discipline (eg Integrative medicine/nursing practitioners), or not involving both CAM and conventional healthcare providers, were excluded. Also excluded were case studies, qualitative studies, studies without a control arm, papers not published in the English language, systematic reviews and meta-analyses. Studies not focussing on the clinical management of a chronic disease, not presenting original data or analyses (expert opinion, commentary or editorial), were incomplete (ie conference proceedings), focussed on specific treatments rather than clinical services (eg provision of a pharmaceutical agent vs care
provided by a pharmacist), or discussed integrated care pathways or integrated managed healthcare systems, were also ineligible. There were no limits placed on outcomes, clinical setting or comparator interventions.
Review criteria
• The search was conducted across seven electronic data- 
| Search strategy
The following electronic databases were searched from their incep- 
| Data collection
The literature search was performed by HE in consultation with a health sciences academic librarian and cross-checked by ML. Two reviewers (HE and ML) independently scanned the title and abstract of every record retrieved. All articles that appeared to meet the selection criteria, as well as those that could not be adequately assessed from the information given, were retrieved and investigated as full text. Data from eligible studies were then extracted independently by one reviewer (HE) and cross-checked by another reviewer (ML) using a customised data extraction form. The form gathered information on the country, study design, model of care, participants, intervention, comparator(s), outcomes and main results. Any disagreements arising during the search, study selection and data extraction processes were resolved by discussion. Where possible, missing data or other clarification was sought from the authors.
| Risk of bias
The risk of bias of included studies was determined using the Cochrane 
| Statistical analysis
Given the considerable clinical and methodological heterogeneity of studies, and that no single comparable outcome was reported in more than three studies, results were not able to be combined by means of meta-analysis; instead, data were synthesised in narrative form.
| RE SULTS
| Summary of the search
The search identified 6926 publications, of which 1858 were not published in English (ie predominantly published in Chinese) and 2080
were duplicate records. Following the removal of these records, 2988
publications remained (Figure 1 ). The screening of titles and abstracts eliminated a further 2955 publications as they did not meet the study selection criteria; the main reasons being the article did not address a chronic disease (n = 1224) or was a literature review/meta-analysis (n = 793). Of the remaining 33 publications, 24 were excluded, primarily as they did not focus on clinical services (n = 10). Consequently, nine publications reporting eight studies were included in this review.
| Included studies
A detailed description of the characteristics of included studies is presented in Table 2 . The following is a brief overview of the studies.
| Study design
The eight included studies (nine publications) consisted of three randomised controlled trials, 32, 33 three pilot randomised controlled trials, 35, 36 one non-randomised controlled trial 39 and one pragmatic observational study. 40 Six trials were multicentred. 32, [34] [35] [36] The duration of studies ranged from 4 to 52 weeks, with a mean study period of 26.3 weeks. 
| Participants
| Interventions
All studies reported conventional/usual care as the comparator, which included (in isolation or in combination) pharmaceutical agents, advice/support/education, physiotherapy and/or other allied and multiple CAM, allied and medical therapies.
36
The interventions were predominantly administered in one of two ways: visits were scheduled on a regular basis (ie weekly, 32, 36 twice a week, 39 five times a week 33 or six times a week 34 ) or the number of visits were capped over the course of the study (ie up to seven sessions over 10 weeks, 37, 38 up to eight visits over 52 weeks 40 
| Outcome measures
The included studies reported 45 distinct outcome measures.
These measures could be grouped into physiological (eg blood pres- 
| Risk of bias of included studies
The eight included studies demonstrated variable risk of bias ( Records after non-English language publications removed (n = 5068)
TA B L E 2 Characteristics of included studies (n = 8) of outcome assessment, and all but one 32 had an uncertain or high risk of bias for allocation concealment. Four of the eight studies received an uncertain or high risk rating for other biases (eg small study effect).
| Effects of intervention
| Clinical parameters
Physiological parameters
Four studies assessed the effectiveness of IHC on twelve distinct physiological end-points, including interferon-gamma (IFN-γ) and conventional care for any of the SF-36 domains at 16 weeks.
The authors did report a clinically relevant difference between groups for the SF-36 vitality domain (−7.3 points, Cohen's d −0.34) at 16 weeks, which favoured IHC.
Psychological parameters
Four studies assessed the effectiveness of IHC on psychological parameters, of which 12 distinct outcome measures were used, including the HADS, SF-36 mental component summary (MCS), sense of coherence-13 (SOC-13) questionnaire 32 ; POMS, symptoms of stress inventory (SOSI) 35 ; patient health questionnaire-8 (PHQ-8), self-efficacy scale (SES), perceived stress scale (PSS), readiness index (RI), problem areas in diabetes (PAID) 40 ; BAI and Beck depression inventory-version 2 (BDI-II). 39 The findings from studies reporting these outcomes were mixed.
In a study of patients with psychological distress, Arvidsdotter et 
Functional parameters
Two studies assessed the effectiveness of IHC on functional status, of which two discrete outcome measures were used, including the Roland-Morris score 36 and the Bartel Index (BI). 34 In patients with lower back pain, 36 those assigned to IHC showed greater improvement in functional status (ie Roland-Morris score) than patients receiving usual care (3.9 vs 11.0) at 12 weeks; notwithstanding, the difference between groups was not statistically significant (P = 0.08). Similarly, in patients with a recent history of ischaemic groups; however, the differences between groups at 4 weeks were not statistically significant. 34 
Disease-specific outcomes
Five studies assessed the effectiveness of IHC on seven diseasespecific outcomes; measures included the FACT-breast-specific (B) and FACT-endocrine-specific (ES) subscales, 35 
| Consumer parameters
One study assessed the impact of IHC on consumer-related parameters, specifically, patient satisfaction. 40 The study found mean patient satisfaction with care scores (measured by a 5-point Likert scale) to be similar for the IHC (adjunctive naturopathic care plus usual care) and usual care groups (2.0 ± 1.1 vs 1.8 ± 0.8, respectively). The statistical significance of the difference between groups was not reported.
| Quality of life
Three studies assessed the effectiveness of IHC on participant quality of life (QoL). 35, 37, 38 However, the findings of the three studies were inconsistent. The study reported by Chen et al 39 
| Workforce parameters
No included studies reported on workforce-related parameters.
| Administrative parameters
No included studies reported on administrative parameters.
| Economic parameters
One study examined the cost-effectiveness of IHC. 38 The study found the difference in quality adjusted life years (QALYs) gained over 1 year, between patients receiving IHC and conventional primary care, was 0.012 (−0.026 to 0.051). While the finding was in favour of IHC, the difference between groups was not statistically significant. The cost/QALY gained ranged between €24,000 and €41,000. While the cost of healthcare provision was higher overall in the IHC group, there was a reduced cost of using conventional healthcare resources (ie lower analgesic use) in the IHC group when compared with conventional primary care.
| D ISCUSS I ON
This review set out to identify and synthesise the best available evidence of the effectiveness of integrative healthcare for the management of any chronic health condition, with consideration given to both patient-and service-related outcomes. The differences between integrative healthcare and conventional/usual care on patient quality of life and various clinical outcomes were varied and inconsistent, while no studies reported the effectiveness of IHC on workforce-or administration-related parameters. Evidence regarding the impact of IHC on patient satisfaction with care was inconclusive.
There was some evidence to suggest that IHC may be more cost-effective than conventional care.
The studies included in this review cautiously indicate a possible benefit of integrative healthcare for some outcomes, in certain patient groups. For example, exposure to IHC was associated with reduced mental fatigue in patients with breast cancer 35 ; improvements in pain and physical function in patients with low back pain 36 ;
positive changes in sense of coherence and symptoms of anxiety and depression in persons with psychological distress 32 ; and improvements in depression symptoms, quality of life and motor/non-motor symptoms in patients with Parkinson's disease. 39 By contrast, standard medical care was found to be more effective than IHC in improving anxiety, endocrine and physical symptoms in patients with breast cancer, 35 and in reducing seizure frequency in infants with cerebral palsy. 33 The discrepancies between studies in patient reported outcomes cannot be attributed to differences in the duration, intensity or disciplinary mix of interventions. Thus, it is possible that some conditions may respond better to an IHC approach than others. Indeed, the findings of a recent survey of Australian health providers and health consumers suggest that an IHC approach may be most appropriate for managing chronic conditions (eg diabetes), but less so for terminal (eg breast cancer) and acute conditions (eg stroke). 28 Differences in risk of bias may also explain to some extent the inconsistent findings between studies. The publications reporting in favour of IHC were more likely to have uncertain/high risk of bias ratings across most domains than publications reporting no differences between groups, or effects in favour of usual care. While low methodological quality may be associated with larger estimates of treatment effect in some disciplines and disease areas, 41, 42 this phenomenon is not universal. 43, 44 As such, the degree to which this phenomenon applies to IHC research requires further exploration.
Few included studies examined the economic benefits of an IHC approach. The only study that reported this outcome suggested that an IHC model of care may be associated with higher service delivery costs than conventional care. 38 However, downstream cost savings attributed to reductions in the use of other conventional healthcare resources (such as analgesics) appeared to offset these IHC service delivery costs. This suggests that while an IHC approach may not be cost saving in some instances (at least for the management of back and neck pain), the cost to avert analgesic use (and potential adverse events) could represent good value for money. 45 The types of therapies included in an integrative healthcare model are likely to influence the extent to which the model will be cost-effective. Indeed, two of the five therapies included in the A notable observation of this review was the considerable heterogeneity of interventions. All IHC models of care were distinct, varying in terms of disciplinary mix (including number and type of therapies), intensity, duration and flexibility (with some models requiring regular visits with a therapist and some allowing patients to access services as-needed). Part of the reason for this variability in models of care has been that until very recently, 28 The findings of this review indicate that employing an integrated approach for chronic disease management may be of some benefit, although, the low volume of studies, and the considerable heterogeneity of study populations/conditions and outcome measures prevents any definitive conclusions. Consequently, there is a clear need for further research in this area. In particular, the need to examine the impact of IHC on both patient-and service-related outcomes in chronic disease populations, over longer periods of time (eg ≥12 months).
Also apparent is the requirement to ensure IHC interventions align with the definition/principles of integrative healthcare; such that the care provided is service-oriented, client-centred, co-ordinated, holistic, evidence-based, interdisciplinary and health-, healing-and wellness-focussed. 28 With all studies carrying an uncertain/high risk of bias across at least three domains of the Cochrane risk of bias tool, there is a clearly a need for future studies to focus on developing robust methodology that limits bias, particularly in relation to allocation concealment and blinding. The authors of future IHC research should also pay particular attention to relevant reporting guidelines, such as the Consolidated Standards of Reporting Trials, 47 to ensure important information is not omitted from research publications.
There are some limitations to this review that are worth noting.
First, limiting the search to articles published in the English language may have omitted studies that could have influenced the conclusions of this review. Second, while the search strategy was systematic and comprehensive, it is possible that some studies could have been missed unintentionally. Third, the method of data extraction (ie extraction by one independent reviewer and verification by another, vs extraction by two independent reviewers), although deemed appropriate for this type of review, may have inadvertently raised the risk of extraction error. Finally, some studies were omitted from the review because of insufficient information (eg inadequate reporting of interventions, methods and/or outcomes). 48, 49 Although it is possible that the findings of these studies could have shaped the conclusions of this review, attempts to contact authors for additional information were unsuccessful.
| CON CLUS IONS
This is the first known systematic review to examine the effectiveness of integrative healthcare in improving patient-and service-related outcomes in populations with chronic disease. The findings highlight several areas where IHC demonstrates potentially promising effects in relation to physiological, psychological, functional and disease-specific outcomes, and in terms of cost-effectiveness. However, given the paucity of high-quality studies, diverse and inconsistent findings, and the variability in outcome measures and study populations, no firm
conclusions can yet be reached about the effectiveness of IHC for the management of chronic disease. The development of well-designed, long-term studies, which evaluate interventions that are more closely aligned with the definition/principles of IHC, are necessary steps for advancing research in this field.
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